Featured

BroadOak invested in Microsize, a CDMO specializing in micronization and particle size control, as part of its launch as an independent business. The full press release is below. Microsize Launched as Independent Pharma Services Company Meets the Growing Need for US-Based API Solubility and Bioavailability Enhancement Services QUAKERTOWN, Pa....

BroadOak Capital Partners advised Bioresource Technology (“BRT”) on the sale of the company to Medix Biochemica.  BRT is a leading provider of high-quality base matrices and other critical raw materials for the IVD industry.The full press release is below.Bioresource Technology joins Medix Biochemica GroupMedix Biochemica...